Effective application of an innovative acemannan-enriched glycolipid sphere dressing in diabetic foot ulcer wound healing: A case report and review of literature.
{"title":"Effective application of an innovative acemannan-enriched glycolipid sphere dressing in diabetic foot ulcer wound healing: A case report and review of literature.","authors":"Shu-Ting Mei, Jie-Jing Li","doi":"10.12998/wjcc.v13.i28.109358","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Aloe vera</i> has been used as a traditional herbal therapy for wound management and dermatological conditions worldwide for thousands of years. Scientific evidence has confirmed that acemannan, the bioactive compound in aloe vera gel, exhibits significant anti-inflammatory and immunomodulatory properties that enhance tissue regeneration. This case report describes the successful application of an innovative acemannan-enriched glycolipid sphere dressing derived from aloe vera gel in diabetic foot ulcer (DFU) treatment, which achieved a clinically remarkable outcome.</p><p><strong>Case summary: </strong>An 80-year-old female patient with a 20-year history of type 2 diabetes mellitus experienced recurrent diabetic foot pain for 15 years. She had multiple hospitalizations due to acute infections and poorly controlled hyperglycemia. Long-term treatments included metformin and gliclazide. Upon presentation, she had a nonhealing wound on her left dorsal foot, diagnosed as a severe DFU (Texas classification: Grade II, stage D). She declined amputation and opted for conservative treatment. The medical team applied an acemannan-enriched glycolipid sphere dressing five times daily to the left calf and foot, avoiding the wound area. Frequency was reduced to three times daily after scab formation. Weight-bearing on the injured foot was avoided. Through in-person and online consultations, the team managed her lifestyle and diet, emphasizing natural foods. After 5 months, the DFU healed without significant scarring or functional loss. No recurrence was observed during the 2-year follow-up.</p><p><strong>Conclusion: </strong>Acemannan-enriched glycolipid sphere dressings promote DFU healing. This suggests the potential of these dressings for treating other refractory wounds.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"13 28","pages":"109358"},"PeriodicalIF":1.0000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362459/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Clinical Cases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12998/wjcc.v13.i28.109358","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Aloe vera has been used as a traditional herbal therapy for wound management and dermatological conditions worldwide for thousands of years. Scientific evidence has confirmed that acemannan, the bioactive compound in aloe vera gel, exhibits significant anti-inflammatory and immunomodulatory properties that enhance tissue regeneration. This case report describes the successful application of an innovative acemannan-enriched glycolipid sphere dressing derived from aloe vera gel in diabetic foot ulcer (DFU) treatment, which achieved a clinically remarkable outcome.
Case summary: An 80-year-old female patient with a 20-year history of type 2 diabetes mellitus experienced recurrent diabetic foot pain for 15 years. She had multiple hospitalizations due to acute infections and poorly controlled hyperglycemia. Long-term treatments included metformin and gliclazide. Upon presentation, she had a nonhealing wound on her left dorsal foot, diagnosed as a severe DFU (Texas classification: Grade II, stage D). She declined amputation and opted for conservative treatment. The medical team applied an acemannan-enriched glycolipid sphere dressing five times daily to the left calf and foot, avoiding the wound area. Frequency was reduced to three times daily after scab formation. Weight-bearing on the injured foot was avoided. Through in-person and online consultations, the team managed her lifestyle and diet, emphasizing natural foods. After 5 months, the DFU healed without significant scarring or functional loss. No recurrence was observed during the 2-year follow-up.
Conclusion: Acemannan-enriched glycolipid sphere dressings promote DFU healing. This suggests the potential of these dressings for treating other refractory wounds.
期刊介绍:
The World Journal of Clinical Cases (WJCC) is a high-quality, peer reviewed, open-access journal. The primary task of WJCC is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of clinical cases. In order to promote productive academic communication, the peer review process for the WJCC is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCC are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in clinical cases.